Although CRISPR technology allows specific genome alterations to be created with relative ease, detection of these events can be problematic. For example, CRISPR-induced double-strand breaks are often repaired imprecisely to generate unpredictable short indel mutations. Detection of these events requires the use of molecular screening techniques such as endonuclease assays, restriction profiling, or high-resolution melt analysis (HRMA). Here, we provide detailed protocols for HRMAbased mutation screening in Drosophila and analysis of the resulting data using the online tool HRMAnalyzer.
MgCl 2 (100 mM) Oligonucleotide primers for polymerase chain reaction (PCR) and high-resolution melt analysis (HRMA)
We recommend using Primer3 (http://bioinfo.ut.ee/primer3) or a similar program to design primers for PCR and HRMA. Design one set of PCR primers to amplify a 300-to 600-bp fragment surrounding the sgRNA target site (
Step 2). Design a second set of HRMA primers to amplify a 45-to 150-bp fragment contained within the sgRNA PCR product (Step 5).
Plasmid DNA miniprep kit (e.g., QIAGEN) Precision Melt Supermix (Bio-Rad) Zero Blunt TOPO PCR cloning kit (Invitrogen)
Equipment
Bullet blender or pestles for homogenization in 1.5-mL microcentrifuge tubes (for adult flies) Centrifuge Heat blocks or water baths at 50˚C and 95˚C HRMAnalyzer (http://www.flyrnai.org/hrma) Microcentrifuge tubes (1.5 mL) PCR tubes RT-PCR (reverse transcription-polymerase chain reaction) machine capable of reading at temperature intervals of 0.1˚C Thermocycler
METHOD

Performing the HRMA Reaction
To generate P-values from HRMA indicating the likelihood of experimental samples containing different sequence versus the controls, at least three control samples (i.e., using wild-type DNA) must be present; however, the quality of output data is improved with additional controls. For the following protocol, we recommend performing at least three control reactions for simple samples (e.g., from diploid flies) and at least eight controls for complex samples (e.g., from mixed cell populations).
1. Prepare genomic DNA from adult flies or cells as follows.
Adult Flies
i. Place an anesthetized fly into a 1.5-mL tube with 50 µL of buffer SB.
ii. Thoroughly homogenize the sample using a bullet blender or pestle.
iii. Centrifuge the sample at maximum speed for 1 min to pellet the remaining tissue fragments.
Transfer the supernatant to a PCR tube. iv. Incubate the supernatant for 1 h at 50˚C followed by 10 min at 95˚C.
Cells
v. Collect 10,000-100,000 cells in a 1.5-mL microcentrifuge tube. Pellet the cells by centrifugation at 5000g for 2 min. vi. Resuspend the cells in 100 µL of buffer SB.
vii. Incubate the sample for 1 h at 50˚C followed by 10 min at 95˚C.
2. Assemble the following PCR to amplify the 300-to 600-bp sequence surrounding the sgRNA target locus. This PCR is designed to amplify products with low specificity using a wide range of primer pairs and will likely produce multiple nonspecific bands. In general, it is not necessary to check the product on a gel, as low concentrations are sufficient for the HRMA reaction and nonspecific products are not a concern.
4. Dilute the PCR products 1:10,000 using H 2 O.
5. Assemble the HRMA reaction using primers that amplify a 45-to 150-bp fragment contained within the sgRNA PCR product. All control sample names must contain the word "control."
Many RT-PCR machines automatically convert fluorescence readings to −dF/dT. The analysis will not work using this format; thus, be sure to export the raw data (usually called RFU data).
8. Convert the file format to .xlsx or .txt 9. Upload the melt data file to HRMAnalyzer at: http://www.flyrnai.org/hrma (Fig. 1A) .
10. Click "Generate Figures."
11. Use the "Data quality cutoff" slider to remove any samples that were not amplified efficiently and click "next."
Samples not amplified efficiently will have considerably lower fluorescence values than other samples and will often lead to false positive results.
12. Select the upper and lower normalization ranges by dragging the vertical bars or entering values directly into the relevant boxes. Click "Generate Figures" and then "Next" (Fig. 1B) .
The upper normalization range should be positioned to the left of the melting region and the lower range below the melting region (Fig. 1B) . Both ranges should cover 3˚C-8˚C, although this parameter is relatively flexible.
The "Overlay" option can be used to shift all melt curves along the horizontal axis such that they cross at a point defined by the "Overlay position" slider. This allows comparison of curve shape independent of the melting temperature and can be useful for separation of heterozygous and homozygous samples. It is generally not required and is not recommended for analysis of samples from complex backgrounds, such as in cell culture experiments in which many different sequences may be present.
13. Click "Generate Figures" to obtain a summary graph of the results with hits shown with blue lines and nonhits with black lines (Fig. 1C) .
The clustering option can be used to group samples likely to have the same composition (e.g., carrying the same mutation). However, this option does not perform well on complex samples in which many sequences are present.
14. Click "Download Data" to retrieve data from each step of the analysis process.
Several files will be downloaded, including the data plotted on the graphs at each analysis step. In addition, a file named "Data_significance.txt" will include a P-value representing the likelihood of each sample containing sequence different from control samples, and a value labeled "Total area" which can be used to rank the results (high values indicate greater difference from control melt curves).
See Troubleshooting.
Analyzing Hits by Sequencing
HRMAnalyzer provides a list of samples likely to have differing sequences from the controls. When working with relatively simple samples, such as those derived from heterozygous mutant flies, this analysis is relatively reliable. However, in cell lines in which many different mutations may be present at potentially low levels, HRMA signals may be weak. It is therefore advisable in these cases to confirm the presence and nature of mutations by sequencing following HRMA.
15. Assemble the following PCR to amplify the region surrounding the mutation. This PCR may require optimization to produce a specific product.
17. Run a 5-µL aliquot of the PCR product on an agarose gel to check that a band of the correct size was produced. 18. If necessary, gel-purify the correct product and elute in 30 µL of H 2 O 19. Assemble a TOPO cloning reaction using the Zero Blunt reagents as follows.
Reagent
Amount to add Purified PCR product 2 µL Salt solution 0.5 µL TOPO vector 0.5 µL 20. Incubate the reaction for 5 min at room temperature.
21.
Transform the DNA into chemically competent E. coli using standard methods. Spread the cells onto plates containing solid LB agar with ampicillin. Incubate overnight at 37˚C. 22. Select individual colonies and culture in 2 mL of LB liquid medium with ampicillin selection overnight at 37˚C. Prepare plasmid DNA minipreps from the overnight cultures using standard methods.
The recommended number of picked colonies is dependent on the source of the samples. When using diploid flies, relatively few colonies can be analyzed to identify all sequences present. Five colonies per sample should be sufficient. When sequencing from cultured cells, many more sequences may be present, so more colonies should be picked and sequenced.
23. Sequence the plasmid DNA constructs using M13F and M13R primers.
24. Perform a local alignment to the experimentally determined starting genomic sequence (if determined), or to a reference genomic sequence, using standard sequence analysis software.
TROUBLESHOOTING Problem (Step 6): The HRMA fluorescence signal is low. Solution: This result suggests that either the first PCR reaction was inefficient or the HRMA amplification step failed. Run products from the first PCR on a gel and check for a band of the correct size. If a band is not present, optimize the reaction or redesign the primers. If a band is present, redesign primers for the HRM reaction and repeat the assay.
that the curves are very similar. If they are not, repeat the assay using fresh control DNA to improve quality.
Problem (Step 24):
Significantly different samples do not contain mutations when analyzed by sequencing. Solution: This can occur when HRMA primers produce nonspecific bands. Run HRMA reaction products on a gel to ensure that a single band is produced.
DISCUSSION
The detection of indel mutations induced using CRISPR requires the use of molecular screening techniques, as no markers are introduced to indicate the mutation event. Several methods are available to screen for indel mutations. For example, where an indel mutation is likely to disrupt a restriction site, restriction profiling can be used to determine the presence and frequency of mutations (Nekrasov et al. 2013; Liang et al. 2014) . Alternatively, endonuclease assays have been developed to detect the heteroduplexes formed when mutant DNA sequences are mixed with wild-type (Cho et al. 2013; Cong et al. 2013; Vouillot et al. 2015) . Finally, HRMA can be used to detect the presence of sequence alterations such as indel mutations (Dahlem et al. 2012; Xing et al. 2012; Bassett et al. 2013) . One advantage of HRMA over other assays is that many samples can be analyzed in parallel with little increase in workload. In addition, HRMA is extremely sensitive and can detect rare mutations or complex mixtures of mutations that may arise from genome editing in cultured cells and might be missed using endonuclease assays. Methods for application of these approaches in Drosophila have been described elsewhere (Bassett and Liu 2014; Beumer and Carroll 2014; Housden et al. 2014 ). Here we have focused on HRMA and data analysis using the HRMAnalyzer tool, as this technique can initially appear complex and is covered less extensively in previous literature.
RECIPES
LB Liquid Medium
In 1 L H 2 O, dissolve 10 g of Bacto Tryptone, 5 g of yeast extract, and 10 g of NaCl. Adjust the pH to 7.5 with NaOH. Sterilize by autoclaving.
Buffer SB 10 mM Tris-HCl (pH 8.2) 1 mM EDTA 25 mM NaCl 400 µg/mL Proteinase K (added fresh before use)
